SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending intensely as the community eagerly awaits the imminent launch of its next-generation BlueBird 6 satellite, seen as a crucial "scale-up proof point" for its space-based cellular network. The "SpaceMob" is buzzing with excitement, discussing the company's long-term potential and market impact, with many dismissing concerns that the event is already "priced in." This highly anticipated launch is generating strong bullish sentiment, positioning ASTS as a key player in the evolving space sector.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is drawing significant attention as its merger target, Infleqtion, continues to announce strategic partnerships and accolades for its commercially viable quantum sensing and computing technologies. The community is actively discussing Infleqtion's perceived undervaluation against sector peers, with many anticipating a substantial re-rating and increased institutional interest once the de-SPAC process concludes and the ticker changes to INFQ.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as the community eagerly anticipates clarity from a pivotal FDA meeting regarding the path forward for its lead asset, sonelokimab. Investors are actively discussing the strong clinical profile of sonelokimab and heightened speculation of a potential acquisition, leading many to believe the stock is significantly undervalued. Despite market volatility and perceived short-seller activity, strong conviction remains that favorable regulatory news could drive substantial upside.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is generating buzz following a series of strategic teaming agreements that position its specialized thin-film solar technology for critical applications across the growing space, aerospace, and defense sectors. The community is actively debating the stock's high volatility and long-term potential for significant contracts, with discussions weighing its innovative solar solutions for lunar missions and drone powering against concerns about its historical dilution.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending after receiving federal regulatory approval to restart its Las Flores Pipeline System, a move perceived as a crucial step toward reactivating its California offshore oil assets under federal oversight. This development has spurred significant community discussion, with many investors anticipating substantial upside and a potential short squeeze, while others remain cautious due to the company's financial concerns and the likelihood of continued state-level legal and permitting challenges.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is generating buzz due to key advancements, including plans to double U.S. manufacturing capacity and initiating pre-commercial air taxi evaluations in Saudi Arabia, building on its recent successful piloted flight in Dubai. Amidst intense sector competition, community discussion also focuses on a lawsuit against a rival and a notable "Sell" rating from a prominent investment bank, with many investors maintaining a bullish long-term outlook on the burgeoning eVTOL market.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending with intense anticipation surrounding a pivotal FDA decision for its drug Narsoplimab (Yartemlea) by December 26th, targeting a life-threatening condition without an approved treatment. This binary event is bolstered by the recent closing of a significant deal with Novo Nordisk, bringing in substantial upfront cash and potential future milestones, along with a $100 million share repurchase program, fueling community expectations for a transformative approval and a notable short squeeze.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is actively trending following news of its strategic expansion, including partnerships with US cities for air taxi trials under a new White House initiative, the acquisition of Hawthorne Airport as a key LA hub, and an agreement with Saudi Arabia for eVTOL deployment. The community is sharply divided, with bulls anticipating a significant breakout in 2026 fueled by these developments and decreasing short interest, while skeptics remain concerned about execution timelines and potential dilution for the pre-revenue company.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending higher following significant insider buying, notably from Apple CEO and Nike board member Tim Cook, who acquired a substantial amount of shares. This high-profile purchase, coupled with the stock trading at multi-year lows, is fueling community optimism for a potential turnaround despite ongoing discussions about pressures from tariffs and weaker demand in China.

Starfighters Space Inc

Starfighters Space Inc. (FJET), a new IPO in the aerospace sector, is trending due to extreme volatility following a significant rally and subsequent sharp pullback. The community is fiercely debating its future, with many anticipating a massive short squeeze driven by its low float and high short interest, while skeptics decry it as a speculative pump-and-dump given its current nil revenue and questions about its core business model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Azenta (NASDAQ:AZTA) Price Target Raised to $44.00 at Needham & Company LLC

Needham & Company LLC boosted their price objective on shares of Azenta from $42.00 to $44.00 and gave the stock a "buy" rating in a research note on Friday...

Azenta, Inc. $AZTA Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC reduced its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 54.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange...

Azenta, Inc. (NASDAQ:AZTA) Given Consensus Recommendation of "Hold" by Brokerages

Azenta, Inc. (NASDAQ:AZTA - Get Free Report) has earned a consensus recommendation of "Hold" from the eight analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated...

New Strong Sell Stocks for Dec. 15

ALG, AZTA and CMG have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 15, 2025.

Stock Repurchase Program Declared by Azenta (NASDAQ:AZTA)

Azenta (NASDAQ:AZTA - Get Free Report) announced that its Board of Directors has approved a stock buyback plan on Wednesday, December 10th, RTT News reports. The company plans to repurchase $250.00...

Natixis Takes Position in Azenta, Inc. $AZTA

Natixis bought a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange...

Azenta Authorizes $250 Million Share Repurchase Program

Azenta Authorizes $250 Million Share Repurchase Program Azenta Authorizes $250 Million Share Repurchase Program PR Newswire BURLINGTON, Mass., Dec. 10, 2025 BURLINGTON, Mass., Dec. 10, 2025...

Federated Hermes Inc. Sells 70,500 Shares of Azenta, Inc. $AZTA

Federated Hermes Inc. lessened its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 9.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional...

New Strong Sell Stocks for December 9th

BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.

Why a $5 Million Bet on Azenta Could Pay Off After a 70% Stock Slide

Key PointsDallas-based Meros Investment Management purchased 159,945 shares of Azenta valued at $4.6 million in the third quarter...

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

AZTA
Azenta Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AZTA News

AZTAAzenta Inc